Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.81
-0.08 (-8.76%)
Bozor ochiq: Aug 12, 2026, 2:45 PM EDT
0.90
+0.01 (0.76%)
Oldingi bozordan keyin: Aug 11, 2026, 7:58 PM EDT
Jasper Therapeutics, Inc., klinik bosqichdagi biotexnologiya kompaniyasi, Qo'shma Shtatlarda mast hujayrali ildiz hujayralari tomonidan qo'zg'atilgan kasalliklarga qarshi terapevtik vositalarni ishlab chiqishga qaratilgan. Kompaniyaning asosiy mahsulot nomzodi - briquilimab, bu mast va ildiz hujayralaridagi CD117 retseptoriga bog'lanish va signalizatsiya qilish uchun ildiz hujayralari omillarini blokirovka qilish uchun ishlab chiqilgan monoklonal antiteladir. U surunkali spontan ürtiker, surunkali indüklanadigan ürtiker va astma kabi turli xil mast hujayralari tomonidan qo'zg'atilgan kasalliklari bo'lgan bemorlar uchun terapevtik vositalarni ishlab chiqish va tijoratlashtirishga qaratilgan. Jasper Therapeutics, Inc. 2018-yilda tashkil etilgan va shtab-kvartirasi Kaliforniyaning Redwood City shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Alex Gray | Head of Investor Relations |
| Dr. Judith Anne Shizuru M.D., Ph.D. | Co-Founder, Member of Scientific Advisory Board & Director |
| Dr. Luca Di Noto Ph.D. | Senior Vice President of Technical Operations |
| Mr. Herbert C. Cross CPA | CFO & Corporate Secretary |
| Mr. Jeetinder Singh Mahal M.B.A. | President, CEO & Director |
| Mr. Matthew Ford | Senior Vice President of Human Resources |
| Mr. Matthew E. Ros | Chief Operating Officer |
| Mr. Thomas G. Wiggans | Executive Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-08-05 | D | |
| 2026-08-03 | 8-K | ea0300286-8k_jasper.htm |
| 2026-07-31 | 8-K | ea0299917-8k_jasper.htm |
| 2026-07-17 | 8-K | ea0298229-8k_jasper.htm |
| 2026-07-16 | 8-K | ea0298316-8k_jasper.htm |
| 2026-06-15 | DEF 14A | ea0293818-01.htm |
| 2026-06-09 | 8-K | ea0294010-8k_jasper.htm |
| 2026-06-01 | 8-K | ea0292909-8k_jasper.htm |
| 2026-05-21 | 8-K | ea0291168-8k_jasper.htm |
| 2026-05-14 | 8-K | ea0290792-8k_jasper.htm |